FranΓ§aisπ See the interactive version (live chart) β
For Equifax, we replayed every analyst price target of the past 12 months and measured the real outcome: 32% were profitable, average return +3% (172 calls). At 3 months: +0% average return (34% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Barclays | 23 | 48% | +11% |
| Needham | 21 | 24% | +1% |
| Wells Fargo | 15 | 20% | -9% |
| Baird | 13 | 31% | +5% |
| JP Morgan | 12 | 42% | +9% |
Is Equifax overvalued, and is it a good time to buy Equifax right now? If you're wondering, here's a recap to make up your own mind: Equifax's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price Γ· earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects β but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Equifax | Sector median (Industrials) |
|---|---|---|
| P/E | 33.5 | 29.2 |
| Forward P/E | 18.8 | 19.5 |
| Net margin | 11% | 11% |
π Equifax is valued in line with its sector (33.5 vs 29.2).
π P/E, PEG, marginβ¦: see the glossary
π΅ Dividend : Equifax pays about $2.12/share/yr β 1.31% yield. what is this?
The analyst consensus on Equifax (EFX) is "Buy" (34 bullish, 0 bearish calls over 12 months). This is not advice: historically, 32% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $222 (+17% vs $190), ranging from $194 to $245 (10 analysts).
Over 1 year, 32% of analyst targets on Equifax were profitable, for an average return of +3% (across 172 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $222 within 12 months, i.e. +17% vs the current price. The most bullish targets $245, the most cautious $194.
Note: analyst targets are 12-month (median $222, +17%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (32%), and the stock's past trajectory.
Its P/E is 33.5, forward P/E 18.8. A forward P/E lower than the current P/E means earnings are expected to grow.
π See the full interactive analysis of Equifax β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.